Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.80
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
1.83
Today|||52-Week Range
7.15
+44.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues30.2M29.7M34.3M40.5M
 
 
 
 
 
Cost of Goods Sold9.0M10.0M10.5M10.5M
 
 
 
 
 
Depreciation And Amortization20.7M18.6M18.2M18.2M
 
 
 
 
 
 
Operating ExpensesGross Income413.0K1.2M5.6M11.7M
 
 
 
 
 
General Expenses26.2M20.8M19.1M20.3M
 
 
 
 
 
Research And Development940.0K528.0K82.0K99.0K
 
 
 
 
 
Total Operating Expenses55.9M49.4M47.8M49.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.7M-19.6M-13.5M-8.7M
 
 
 
 
 
Extraordinary Credit4.9M0.001.2M25.3M
 
 
 
 
Extraordinary Charge-30.0M-800.0K-31.0K-884.0K
 
 
 
 
 
Interest Expense On Debt11.0M9.0M9.2M9.3M
 
 
 
 
 
Other Expenses-23.8M0.000.00-25.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-85.7M-29.4M-21.6M6.4M
 
 
 
 
 
Income Taxes-413.0K-55.0K-40.0K-27.0K
 
 
 
 
 
Net Income-86.1M-29.5M-21.6M6.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.0M10.0M10.0M11.1M
 
 
 
 
 
Shares To Calculate EPS Diluted10.0M10.0M10.0M16.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$8.92-$2.94-$2.16$0.42
 
 
 
 
 
EPS Diluted-$8.59-$2.94-$2.16$0.42